Friday, Nov 1, 2024 · SEC filings
What the smart money revealed on Nov 1
346 insider filings came in. We hid 52 planned (10b5-1) sellers and 200 people whose filings were routine, like grants and tax withholding.
3 insiders at CalciMedica (CALC) bought $475K of stock
Roles: CEO, Chief Business Officer, Director. Several insiders buying in the same few days is rare.
Peoples Financial (PFBX) CEO/President Chevis Swetman bought $300K
16,883 shares on the open market. Not a grant or an option exercise.
Tyra Biosciences (TYRA) CFO Alan Fuhrman bought $152K
9,500 shares on the open market. Not a grant or an option exercise.
Bankwell Financial Group (BWFG) Director Lawrence Seidman bought $145K
4,976 shares on the open market. Not a grant or an option exercise. Their past buys: 9 of 10 checked quarters beat the typical stock 6 months later.
Crossfirst Bankshares (CFB) Director George Bruce bought $100K
100 shares on the open market. Not a grant or an option exercise.
Altice USA (OPTU) Director Patrick Drahi sold $19.7M
Not marked as a planned 10b5-1 sale. Sold 2% of the shares they held directly. Still holds 35.64M shares.
Royal Caribbean Cruises (RCL) Director Richard Fain sold $9.16M
Not marked as a planned 10b5-1 sale. Sold 17% of the shares they held directly. Still holds 210,021 shares.
First Business Financial Services (FBIZ) Pres&CEO First Business Bank James Hartlieb sold $274K
Not marked as a planned 10b5-1 sale. Sold every share held directly.
Show 14 more real buys
Show 48 more real sales
13F season
Holdings as of Sep 30, 2024 are due Nov 14
58 funds have filed so far. 54 filed for the quarter before.
Biggest real insider buys, Oct 26–Nov 1
Open-market buys by officers and directors, filed in the 7 days up to Nov 1.
Free weekly email
Each week's biggest real insider buys, cluster buys and fund moves, every one dated. One email a week. Unsubscribe in one click.